How many institutions held ABUS - Arbutus Biopharma Corp - Common Shares, without par value in Q2 2023?

109 institutional investors reported ABUS - Arbutus Biopharma Corp - Common Shares, without par value for Q2 2023. Use the holders table for investor-level position and value details.

Arbutus Biopharma Corp - Common Shares, without par value (ABUS)

Q: What does CUSIP 03879J100 represent in this 13F holders report?

CUSIP 03879J100 is the security identifier for ABUS - Arbutus Biopharma Corp - Common Shares, without par value used to aggregate holder disclosures.

CUSIP: 03879J100

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Shares, without par value
Shares outstanding: 197,420,670
Total 13F shares: 66,235,432
Share change: +3,513,706
Total reported value: $152,407,843
Put/Call ratio: 69%
Price per share: $2.30
Number of holders: 109
Value change: +$7,387,882
Number of buys: 48
Number of sells: 53

Quarterly Holders Quick Answers

What is CUSIP 03879J100?
CUSIP 03879J100 identifies ABUS - Arbutus Biopharma Corp - Common Shares, without par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 03879J100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	4.3%	8,464,086	$25,646,179	—	31 Mar 2023	13F
Whitefort Capital Management, LP	13F	Company	3.8%	7,500,026	$22,725,079	—	31 Mar 2023	13F
Two Seas Capital LP	13F	Company	3.8%	7,464,724	$22,618,114	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	2.9%	5,641,202	$17,092,842	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	2.5%	4,882,607	$14,794,298	—	31 Mar 2023	13F
Rubric Capital Management LP	13F	Company	2.1%	4,195,072	$12,711,068	—	31 Mar 2023	13F
Hudson Bay Capital Management LP	13F	Company	1.4%	2,736,426	$8,291,371	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	1.3%	2,657,605	$8,052,543	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	2,287,913	$6,932,376	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	1%	2,068,052	$6,266,198	—	31 Mar 2023	13F
FourWorld Capital Management LLC	13F	Company	1%	2,000,090	$6,060,273	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.84%	1,660,566	$5,032,000	—	31 Mar 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	0.7%	1,376,523	$4,170,865	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.48%	949,890	$2,878,167	—	31 Mar 2023	13F
Assenagon Asset Management S.A.	13F	Company	0.41%	817,574	$2,477,249	—	31 Mar 2023	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.32%	623,987	$1,890,681	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.21%	422,681	$1,280,722	—	31 Mar 2023	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.2%	392,843	$1,190,314	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.19%	369,777	$1,120,424	—	31 Mar 2023	13F
William H. Collier	3/4/5	President and CEO, Director	— mixed-class rows	1,082,500 mixed-class rows	$1,101,985	—	01 Feb 2023	3/4/5
PRIMECAP MANAGEMENT CO/CA/	13F	Company	0.18%	345,900	$1,048,077	—	31 Mar 2023	13F
BANK OF MONTREAL /CAN/	13F	Company	0.16%	317,455	$981,221	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.16%	308,969	$936,176	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.15%	294,165	$891,210	—	31 Mar 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.14%	279,832	$847,891	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.14%	274,991	$833,000	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.14%	274,457	$832,000	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.14%	270,593	$819,897	—	31 Mar 2023	13F
Deutsche Girozentrale DekaBank	13F	Individual	0.13%	250,000	$734,000	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.11%	221,138	$670,049	—	31 Mar 2023	13F
Tejara Capital Ltd	13F	Company	0.1%	200,000	$606,000	—	31 Mar 2023	13F
FMR LLC	13F	Company	0.09%	186,717	$565,753	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.08%	163,895	$496,602	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.08%	159,127	$482,000	—	31 Mar 2023	13F
Elizabeth Howard	3/4/5	EVP, GC, Compliance	— mixed-class rows	364,724 mixed-class rows	$437,862	—	01 Feb 2023	3/4/5
JANE STREET GROUP, LLC	13F	Company	0.07%	136,288	$412,952	—	31 Mar 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0.06%	119,193	$361,155	—	31 Mar 2023	13F
ALPS ADVISORS INC	13F	Company	0.05%	107,107	$324,534	—	31 Mar 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.05%	99,100	$300,273	—	31 Mar 2023	13F
ROYAL BANK OF CANADA	13F	Company	0.05%	91,695	$277,000	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.04%	87,977	$266,570	—	31 Mar 2023	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.04%	85,604	$259,380	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.04%	71,957	$218,030	—	31 Mar 2023	13F
Jump Financial, LLC	13F	Company	0.03%	68,974	$208,991	—	31 Mar 2023	13F
LMR Partners LLP	13F	Company	0.03%	60,000	$181,800	—	31 Mar 2023	13F
MetLife Investment Management, LLC	13F	Company	0.03%	58,981	$178,713	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	0.03%	57,558	$174,401	—	31 Mar 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	57,300	$173,619	—	31 Mar 2023	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.03%	54,832	$166,141	—	31 Mar 2023	13F
Clear Harbor Asset Management, LLC	13F	Company	0.03%	53,000	$160,590	—	31 Mar 2023	13F

Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q2 2023

As of 30 Jun 2023, Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 66,235,432 shares. The largest 10 holders included BlackRock Inc., Two Seas Capital LP, Whitefort Capital Management, LP, VANGUARD GROUP INC, MORGAN STANLEY, Rubric Capital Management LP, Hudson Bay Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, Woodline Partners LP, and CITADEL ADVISORS LLC. This page lists 109 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

120

Q2 2023 holders

109

Holder diff

-11

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.